Exogenous pancreatic-like enzymes are recovered in the gut and improve growth of exocrine pancreatic insufficient pigs.
The exocrine pancreatic insufficient (EPI) pigs grow less due to different disturbances in feed digestion, absorption, and retention. Use of pancreatic-like enzymes of microbial origin in pigs may improve feed use and performance in slow-growing pigs. The aim was to study gut recovery and effectiveness of pancreatic-like enzymes of microbial origin supplementation on pig performance. Six male pigs 10 to 12 kg BW underwent pancreatic duct ligation surgery to induce total exocrine pancreatic insufficiency (EPI). Three cannulas to access the gastrointestinal tract content were installed in stomach, duodenum, and ileum in EPI pigs and in 3 control (healthy) pigs. One month after surgery, enzymes were given before feeding and digesta samples were collected for analyses. The BW of EPI pigs did not increase during 1 mo following surgery (11.7 vs. 11.6 kg BW); however, BW increased after 1 wk of enzyme supplementation (12.1 kg BW). Coefficient of fat and N absorption increased (P < 0.05) in EPI pigs after enzyme supplementation. Activity of amylase, lipase, and protease in chyme samples of EPI pigs was very low compared to controls. In EPI pigs after enzyme supplementation, amylase activity increased from 5.32 to 72.9 units/mL but remained lower than that of healthy pigs (162.7 units/mL). Lipase activity increased from 79.1 to 421.6 units/mL, which was similar to that of controls (507.3 units/mL). Proteolytic activity increased from 7.8 to 69.7 units/mL but still did not reach control pigs (164.3 units/mL). In conclusion, exogenous microbial enzymes mimic endogenous pancreatic enzymes being recovered along the lumen of the gastrointestinal tract. These enzymes might be a useful tool to stimulate growth of slower-growing pigs after the weaning period.
Department of Biology, Lund University, 223 62 Lund, Sweden. Stefan.Pierzynowski@biol.lu.se
S
S
Pierzynowski
K
K
Szwiec
J L
JL
Valverde Piedra
D
D
Gruijc
S
S
Szymanczyk
P
P
Swieboda
O
O
Prykhodko
O
O
Fedkiv
D
D
Kruszewska
R
R
Filip
J
J
Botermans
J
J
Svendsen
G
G
Ushakova
T
T
Kovalenko
I
I
Osadchenko
K
K
Goncharova
G
G
Skibo
B
B
Weström
D000681:Amylases / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D000818:Animals; D001835:Body Weight; D004305:Dose-Response Relationship, Drug; D010188:Exocrine Pancreatic Insufficiency / Q000378:metabolism / Q000662:veterinary*; D005243:Feces / Q000737:chemistry; D008049:Lipase / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D008297:Male; D010183:Pancreatic Ducts / Q000601:surgery*; D010447:Peptide Hydrolases / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D013552:Swine; D013553:Swine Diseases / Q000378:metabolism / Q000473:pathology*
D008049:Lipase; D000681:Amylases; D010447:Peptide Hydrolases